Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2007
CompletedFirst Posted
Study publicly available on registry
July 17, 2007
CompletedJuly 1, 2011
June 1, 2011
July 13, 2007
June 29, 2011
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease
You may not qualify if:
- Intraocular or refractive surgery in the study eye within 3 months prior to study start
- Unwilling to discontinue use of contact lenses during the run-in and duration of the study
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye Center Northeast
Bangor, Maine, 04401, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Roger Vogel, MD
Sirion Therapeutics
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 13, 2007
First Posted
July 17, 2007
Last Updated
July 1, 2011
Record last verified: 2011-06